-+ 0.00%
-+ 0.00%
-+ 0.00%

*Minerva Neurosciences: FDA Confirms Requirement for Confirmatory Study of Roluperidone for Negative Symptoms in Schizophrenia >NERV

Dow Jones·08/14/2025 20:46:00

Please log in to view news